Loading…
Loading…
Atlatl Advisers LLC acquired a new stake in shares of Illumina, Inc. (NASDAQ: ILMN) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 35,165 shares of the life sciences company's stock, valued at approximately $9,624,000. Illumina
Illumina (ILMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Illumina (ILMN) is rated a Buy, driven by robust demand for consumables and NovaSeq X instruments, supported by favorable market dynamics and regulatory tailwinds. NovaSeq X accounts for 59% of consumable revenues, up from 44% in Q2'25, highlighting strong uptake and positioning ILMN to capture expanding diagnostic consumables market share. Management guides for FY2026 revenue of $4.60–$4.64 billion and analysts expect EPS of $5.36, reflecting double-digit upside with a fair forward P/S target of 9.75x ($293.77).
Illumina's Q3 results may benefit from strong clinical demand, NovaSeq X adoption, instrument placements and innovations despite persistent weakness in research markets.
DRAGEN Ultra, BioInsight Platform Workflow Orchestrator, and BioInsight Platform Learning Cohorts are now available in early access, incorporating new AI-driven approaches to analysis, automation, and discovery The tools automate end-to-end informatics processes at scale and help customers build private data lakes to drive scientific and clinical research insights SAN DIEGO, Oct. 21, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today introduced three early-access capabilities on its BioInsight Platform that help researchers move faster from sequencing data to discovery. BioInsight Platform Workflow Orchestrator enables laboratories to operate consistent, traceable sequencing and informatics operations at scale.
SAN DIEGO, Oct. 20, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that members of its management team will participate at the following investor conference: Upcoming Investor Conference UBS Global Healthcare Conference on November 10, 2026 The fireside chat is scheduled for 07:15am PT (10:15am ET). The webcast can be accessed through the Events & Presentations section of Illumina's website at investor.illumina.com.
Rate and energy headlines have kept the broad market jumpy, yet one sector keeps finding buyers. Healthcare has led on days when the S&P 500 slipped, and the Nasdaq Biotechnology Index has pushed to record highs.
First Citizens Bank and Trust Co. purchased a new position in Illumina, Inc. (NASDAQ: ILMN) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 3,511 shares of the life sciences company's stock, valued at approximately $961,000. A number of